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Radioactive radon is an inert gas that migrates from soil and rock
and can accumulate in enclosed areas such as homes and under-
ground mines. The radioactive decay of trace amounts of uranium
in the Earth’s crust through radium is the source of radon, or more
precisely the isotope radon-222. Studies have demonstrated a
significant and dose-related excess of lung cancer in radon-
exposed miners (National Research Council, 1988; Samet 1989;
Lubin et al, 1995). Results from studies of residential radon expo-
sure have been less consistent, but together these studies suggest a
modest positive association between indoor radon and lung cancer
risk (Lubin and Boice, 1997).
Several recent ecologic studies have found increased rates of
leukaemia and other cancers in regions with elevated levels of
radon in homes (Lucie, 1989; Alexander et al, 1990; Henshaw
et al, 1990), although a small case–control study found no associa-
tion between childhood cancer and radon exposure (Stjernfeldt et
al, 1987). Two of the reports suggested that effects may be more
pronounced for childhood leukaemias, specifically myeloid
leukaemias (Alexander et al, 1990; Henshaw et al, 1990). Despite
the considerable skepticism with which these reports were met,
more rigorous study of the potential risks associated with radon
was felt to be warranted (Peto, 1990).
Through a collaboration between investigators of the Children’s
Cancer Group (CCG) and the US National Institute of
Environmental Health Sciences (NIEHS), measurement of indoor
radon was incorporated into an ongoing national case–control
interview study of childhood acute myeloid leukaemia (AML)
designed to assess the role of environmental risk exposures in the
aetiology of AML. Availability of extensive questionnaire data on
potential leukaemia risk factors in conjunction with clinical and
laboratory data for a large sample of childhood AML cases
provided a good opportunity to study a possible association
between indoor radon and childhood leukaemia.
Results from a parallel study of childhood acute lymphoblastic
leukaemia (ALL) conducted by the CCG and the US National
Cancer Institute have recently been reported (Lubin et al, 1998)
and do not support a risk for ALL associated with residential radon
exposure. Results regarding AML are reported here.
MATERIALS AND METHODS
Case and control selection
In the interview study, cases were identified as individuals diag-
nosed with AML between 1 January 1989 and 31 March 1993, and
registered through member institutions of CCG, a paediatric coop-
erative clinical trials group conducting therapeutic, biological and
epidemiological research. Over 120 institutions in the USA and
Canada participate in the CCG.
All newly diagnosed patients with AML or myelodysplastic
syndrome (MDS), as defined by the French–American–British
(FAB) classification, less than 18 years of age at time of diagnosis,
were ascertained and eligibility assessed. To be eligible, the family
of the index child must have had a telephone in the household in
which they resided at the time the child was diagnosed and resided
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in the USA or Canada for a minimum of 2 weeks prior to the time
of diagnosis; the case’s physician must have provided consent to
contact the parents; and the biological mother must have been
available, English-speaking and willing to be interviewed.
Regional population controls were enrolled for comparison with
cases. One control per case was selected for each child with AML
classified as M0, M1, M2, M4, or M5 morphology. Two controls
per case were selected for cases with MDS or AML of M3, M6, or
M7 morphology, to increase statistical power for subgroup
analyses. Controls were matched to cases on age (± 25% of age at
diagnosis, with a maximum allowable difference of 2 years), race
(white, black, other) and geography (area code and exchange).
Control selection utilized a random digit dialling (RDD) procedure
(Robison and Daigle, 1984). Mothers and fathers of study subjects
were interviewed separately by telephone. Interviews included
detailed information on a wide range of topics, including a
complete medical history, parental occupational history, household
exposures, personal habits, parental recreational drug use and
postnatal exposures. A focus on specific factors, including pesti-
cides, solvents and petroleum products, maternal marijuana,
parental cigarette smoking and alcohol consumption use was
included in an effort to confirm previous results (Buckley et al,
1989; Robison et al, 1989; Severson et al, 1993).
Eligibility criteria for participation in the radon measurement
component of the study included: (1) the residence of the child at
the time of diagnosis (index residence) was occupied at time of
interview by one or both parents of the study subject; (2) the
entrance to the index residence was no higher than the floor above
street level; (3) the parent currently occupying the index residence
did not plan to move within the subsequent 6 months; and (4) the
child lived in the index residence a minimum of 5 years prior to the
time of leukaemia diagnosis (or their entire lifetime for those cases
under 5 years of age at diagnosis). This last criterion requiring a
minimum time spent in the index residence accounted for most of
the 300 cases and 313 controls that were not considered eligible
for the radon measurement study. Nineteen cases with Down’s
syndrome were excluded from the radon measurement study due
to their approximate 14-fold higher risk of AML compared to the
general population and the potentially distinct aetiology associated
with this condition (Robison et al, 1984).
Radon measurements and exposure assessment
Upon completion of the telephone interview, eligible cases and
controls were asked to participate in the radon measurement study.
A total of 173 cases and 254 controls fulfilled the eligibility
requirements and participated. Each willing participant was
mailed general background information about indoor radon, two
alpha-track radon detectors (TechOps-Landauer, Glenwood, IL,
USA), instructions for the placement of detectors, a toll-free tele-
phone number to call with any questions about the monitors and a
brief interview guide, for use during a follow-up telephone inter-
view. A sample of subjects were mailed a third detector for side-
by-side placement with another detector for the purpose of quality
control. Another quality assurance method involved blind reading
of spiked and blank detectors.
Participants were telephoned by an interviewer 2 weeks after
detectors and related materials were mailed. Interviewers verified
that detectors had been received, answered questions about indoor
radon and the radon monitors, and obtained supplemental residen-
tial history data. The 5- to 10-min interview enabled interviewers
to determine the appropriate locations for monitor placement and
ascertain how much time the child usually spent on different levels
of the home, outdoors, at school and in other indoor locations.
Participants were instructed to place one detector in the child’s
bedroom and a second detector in a designated room on the lowest
living level on which the child spent a substantial amount of time
during the day. In homes where the bedroom and usual daytime
room were on the same level, the lowest level of the home where
the subject spent the second greatest number of hours was chosen
for the second detector. In homes with only one level, one monitor
was placed in the child’s bedroom and the other was usually
placed in the living room or den. Participants were instructed to
tack the monitors to the wall above the door or another location
away from windows and air returns in the designated rooms,
record the date the monitors were unsealed and placed, and return
a completed radon detector tracking form with the signed consent
form. Monitor placement was verified by comparing rooms listed
on the tracking form returned by the respondent with the indicated
rooms as instructed by the interviewer.
Six months after monitor placement, a telephone contact was
made to confirm monitor status, remind participants that the study
was ongoing and reinforce the importance of notifying the study
office in the event of problems or loss of monitors and/or plans to
move from the index residence. One year after monitor placement,
participants were mailed packaging materials and instructions for
returning monitors. Study participants requesting results of radon
measurements for their home were sent a copy of the results and an
Environmental Protection Agency (EPA) brochure on radon.
While radon exposure was measured in pico-Curies per litre
(pCi l–1), all of the results are reported in Becquerels per cubic
metre (Bq m–3). The conversion factor is 37 Bq m–3 to 1 pCi l–1.
Remediation of radon is recommended for homes that exceed
148 Bq m–3 by the US EPA, and 200 Bq m–3 by the British
National Radiological Protection Board (NRPB).
Data were collected on the number of waking and sleeping
hours spent on different levels of the index home and at other
indoor and outdoor locations from birth through the reference/
diagnosis date. To better estimate hours spent at home, summary
information was collected for two time periods: before and after
the child first attended school or day care at least 30 hours per
week. We computed a time-weighted average (TWA) radon
concentration, simultaneously weighting the radon concentration
specific to each level of the home by the average time spent on
each level, based on reported activity patterns for the two time
periods. Measurements were not made in previous homes or in
other indoor or outdoor locations. Time spent away from home
was included as a separate variable in statistical models estimating
the relative risks associated with residential radon exposure. In
14% of homes no radon measurement was available for a level of
the home where the index child spent one or more hours per day.
In this situation, a valid measurement for another level was used to
estimate the radon concentration on the missing level, based on
regression models derived using data from all case and control
homes where valid measures were available for both of the
relevant levels. These regression relationships were quite linear,
with high correlation (r = 0.81 for below versus at ground level,
r = 0.97 for at versus above ground level).
An unmatched analysis was performed since a substantial loss
in sample size would result if analyses were restricted to
case–control pairs. Risk from radon exposure was evaluated
taking into consideration other risk factors that had been identified902 M Steinbuch et al
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in the interview study. The radon-associated relative risks of AML
were estimated by calculating odds ratios (OR) as the estimate of
relative risk. Adjusted ORs and 95% confidence intervals (CI)
were derived using unconditional logistic regression (Breslow and
Day, 1980). Final models were adjusted for maternal education,
family income, maternal race and age. Taking into account gender
and the number of hours per day the index child spent away from
home (outdoors or at other indoor locations) did not appreciably
alter the results. Tests for linear trend were based on the logistic
regression analysis treating the separate categories of radon
concentration as ordinal. Because childhood environmental expo-
sures are less likely than pregnancy and parental factors to affect
risk for infant leukaemia, we estimated the risk associated with
radon separately for children younger than 2 years of age and age
2 and over. Analyses were also conducted for the subset of subjects
who lived only in one home (lifetime subset), allowing for assess-
ment of lifetime household radon exposure and minimizing the
misclassification of lifetime exposure that results from measuring
only the current home.
RESULTS
Table 1 summarizes the participation rates and reasons for non-
response. A total of 173 case and 254 control families participated
in the radon measurement study.
Radon measurement error was assessed by comparing the paired
readings based on side-by-side detectors placed in 37 (9%) of the
study participant homes. The coefficient of variation (CV) was
9%. In addition, there were 50 spiked radon detectors exposed in a
controlled laboratory setting (RUST Geotech, Incorporated, Grand
Junction, CO, USA) at three separate radon exposures in Bq day–1
m–3 (364.3, 730.6 and 1088). The mean reported exposure in 
Bq day–1 m–3, respectively, were 420, 767 and 1138, resulting in
small differences between the target exposures and the mean
reported exposures. The overall CV was 13.5% for the spiked
radon detectors. Of the 32 blank detectors tested, 19 (59%) were
reported as below the detectable threshold of 3 Bq m–3, and the
average radon level for the remaining 13 detectors was 6 Bq m–3.
Although they provide some reassurance that dosimetric errors
were small, a source of error that these quality assurance measures
cannot address is year-to-year variability in the actual radon levels,
which can produce a mismatch between the level that was
measured and the risk-relevant exposure that was experienced by
the study participant.
The frequency and percentages of cases and controls for
selected demographic variables are provided in Table 2 for all
subjects and for those living their entire life in the measured home.
Descriptive statistics for the TWA radon concentration for cases
and controls are presented in Table 3. The arithmetic mean of the
time-weighted radon concentrations for cases and controls was
49.8 and 56.0 Bq m–3, respectively, in the overall population, and
50.9 and 54.0 Bq m–3, respectively, in the lifetime subset.
In examination of the aggregate data, no dose–response rela-
tionship was observed between risk of AML and postnatal indoor
Table 1 Study participation rates for interview and radon measurement
studies
Cases Controls
n (%) n (%)
Eligible participants for interview study 638 771
Maternal interview completed 530 (83.1) 612 (79.4)
Non-response 108 (16.9) 159 (20.6)
Physician refusal 28 (4.4) –
Parental refusal 53 (8.3) 142 (18.4)
Lost to follow-up 13 (2.0) 13 (1.7)
Othera 14 (2.2) 4 (0.5)
Matched sets for interview study (at least 517 (81.0) 610 (79.1)
one control per case)
Ineligible subjects for radon measurement study 300 313
Eligible participants in radon measurement study 217 297
Refusal 13 (6.0) 11 (3.7)
Invalidb 31 (14.3) 32 (10.8)
Radon measurement study participants 173 (79.7) 254 (85.5)
aMother not available, language. bRadon detectors not retrieved or placement
not confirmed.
Table 2 Frequency distribution for demographic variables
Overall (n = 427) Lifetime subset (n = 284)
Cases Controls Cases Controls
Variables n (%) n (%) n (%) n (%)
Sex
Male 83 (48.0) 128 (50.4) 52 (48.1) 86 (48.9)
Female 90 (52.0) 126 (49.6) 56 (51.9) 90 (51.1)
Maternal education
≤ High school 68 (39.3) 82 (32.3) 42 (38.9) 57 (32.4)
Post-high school 63 (36.4) 88 (34.6) 37 (34.3) 62 (35.2)
College/post-graduate 42 (24.3) 84 (33.1) 29 (26.9) 57 (32.4)
Maternal race
White 152 (87.9) 238 (93.7) 96 (88.9) 165 (93.7)
Non-white 21 (12.1) 16 (6.3) 12 (11.1) 11 (6.2)
Family income (´ 1000)
< $20 18 (10.4) 26 (10.2) 12 (11.1) 17 (9.7)
$ 20–$40 67 (38.7) 80 (31.5) 41 (38.0) 61 (34.7)
> $40 88 (50.9) 148 (58.3) 55 (50.9) 98 (55.7)
Age (years)
< 2 37 (21.4) 59 (23.2) 37 (34.3) 59 (33.5)
³ 2 136 (78.6) 195 (76.8) 71 (65.7) 117 (66.5)Indoor radon exposure and risk of childhood AML 903
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residential radon exposure, with adjusted ORs of 1.16 (95% confi-
dence interval (CI) 0.7–1.8) and 1.12 (95% CI 0.6–2.0) for 37–100
and > 100 Bq m–3 compared with < 37 Bq m–3 (Table 4). However,
there was a statistically significant age–radon interaction in the
overall and in the lifetime subset. Among children < 2 at diagnosis,
there was an inverse association between radon level and AML
risk (test for trend, P = 0.03), whereas among those ³ 2 the
estimated relative risk was increased among those with higher
radon exposure (overall test for trend, P = 0.07; lifetime subset test
for trend, P = 0.01) (Table 5). In addition, the adjusted ORs for
higher radon exposure increased with increasing age [2–9 years:
1.6 (95% CI 0.7–3.9) and 2.3 (95% CI 0.7–7.3) for 37–100
and > 100 Bq m–3 respectively, compared with < 37 Bq m–3;
10–17 years: 4.3 (95% CI 1.2–15.4) and 4.6 (95% CI 0.6–39.3)
for 37–100 and > 100 Bq m–3 respectively, compared with
< 37 Bq m–3] (data not shown), but the limited sample size
precluded finer stratification.
A number of potential confounding variables were examined,
including the region where the family lived, the year the home was
built, the type of dwelling (single-family versus other), urbaniza-
tion, opening of windows to ventilate the home, and smoking
status of the mother and father of the index child. These factors did
not appreciably alter the results in the multiple logistic regression
analysis (data not shown). Furthermore, stratification by FAB
morphology did not reveal increased risks for specific morpho-
logic subgroups (data not shown). It should be noted, however,
that small numbers precluded meaningful analysis by FAB
morphology.
DISCUSSION
Radon has long been recognized to be a lung carcinogen in occu-
pationally exposed underground uranium and hard-rock miners
(National Research Council, 1997). Data from studies of miners
have been used to estimate that a substantial proportion of lung
cancer deaths in the USA could be due to indoor radon (Lubin
et al, 1995). Several case–control studies of lung cancer risk
associated with residential radon have been published with
varying results (Schoenberg et al, 1990; Alavanja et al, 1994;
Table 3 Mean, median, range and geometric mean of time weighted
average radon concentration (Bq m–3) for cases and controls in overall and
lifetime subset
Radon concentration (Bq m–3)
Overall Lifetime subset
Cases Controls Cases Controls
(n = 173) (n = 254) (n = 108) (n = 176)
Arithmetic mean 49.8 56.0 50.9 54.0
Median 32.1 30.6 35.1 30.9
Range 1.7–518.6 2.0–558.3 1.7–518.6 2.0–558.3
Geometric mean 28.6 30.2 29.4 29.3
Table 4 Risk estimates and corresponding 95% confidence intervals for indoor residential TWA radon concentration and childhood AML
TWA radon
Overall (173 cases and 254 controls) Lifetime subset (108 cases and 176 controls)
Concentration No. of No. of Crude 95% CI ORa 95% CI No. of No. of Crude 95% CI ORa 95% CI
(Bq m–3) cases controls OR cases controls OR
<37 96 143 1.0 1.0 57 98 1.0 1.0
37–100 53 76 1.04 0.7–1.6 1.16 0.7–1.8 37 56 1.14 0.7–1.9 1.22 0.7–2.1
>100 24 35 1.02 0.6–1.8 1.12 0.6–2.0 14 22 1.09 0.5–2.3 1.25 0.6–2.7
P-trend 0.58 0.45
aModel adjusted for maternal race, maternal education, family income and age.
Table 5 Risk estimates and corresponding 95% confidence intervals for indoor residential TWA radon concentration and childhood AML,
stratified by age
Overall Lifetime subset
Age TWA radon No. of No. of 95% No. of No. of 95%
(years) concentration (Bq m–3 cases controls ORa CI cases controls ORa CI
<2
<37 23 22 1.0 23 22 1.0
37–100 10 25 0.32 0.1–0.9 10 25 0.32 0.1–0.9
>100 4 12 0.30 0.1–1.1 4 12 0.30 0.1–1.1
P-trend 0.03 0.03
³2
<37 73 121 1.0 34 76 1.0
37–100 43 51 1.62 1.0–2.7 27 31 2.18 1.1–4.4
>100 20 23 1.59 0.8–3.2 10 10 2.79 1.0–7.8
P-trend 0.07 0.01
aModel adjusted for maternal race, maternal education, family income and age.904 M Steinbuch et al
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Letourneau et al, 1994; Pershagen et al, 1994). Together, these
studies are consistent with the data from miners and suggest a
modest positive association between indoor radon and lung cancer
risk (Lubin and Boice, 1997). A recent report from the UK (Darby
et al, 1998) also supports a link between residential radon exposure
and risk of lung cancer.
Evidence for a link between radon and other cancers is more
limited. A review of 11 studies of radon exposed miners found no
overall increased mortality from all non-lung cancers combined,
although increased risks for certain cancers, including leukaemia,
were observed (Darby et al, 1995). Several ecological studies
suggested the possibility of increased risk for childhood leukaemia
(Lucie, 1989; Alexander et al, 1990; Henshaw et al, 1990) and
AML (at all ages) (Alexander et al, 1990; Henshaw et al, 1990;
Forastiere et al, 1992; Viel, 1993), as well as for other sites
(Henshaw, 1990; Eatough and Henshaw, 1993), in regions where
average indoor radon concentrations are higher. These reports
have been controversial (Bowie, 1990; Mole, 1990; Miller et al,
1993), and a reanalysis of the Henshaw data (Butland et al, 1990)
was less suggestive of a radon effect. Other negative studies
(Muirhead et al, 1991; Miller et al, 1993) highlight problems of
potential confounding when data are based on large units of
analysis such as at the regional or country level. A more recent
study by Thorne et al (1996) found no difference in overall child-
hood cancer rates in postcode sectors of England with ‘high’ and
‘low’ radon levels. High radon areas, however, had significantly
increased rates of neuroblastoma (P = 0.02) and a non-significant
increase in childhood AML (P = 0.11).
It has been argued that the marrow dose from radon may be
greater than predicted from usual dosimetry models and have
developed a theoretical model for estimating the dose to bone
marrow from radon daughters (Henshaw et al, 1990; Richardson
et al, 1991). The biological plausibility of a radon–leukaemia link
was further supported by an early report that the frequency of
mutations in the HPRT (hypoxanthine phosphoribosyl transferase)
gene was associated with radon levels measured in homes (Bridges
et al, 1991). A subsequent larger study failed to confirm this link
(Cole et al, 1996), although in another study, homozygous muta-
tions of glycophorin A were increased in underground miners with
modest radon exposure (Shanahan et al, 1996).
The current study provides little overall evidence of an associa-
tion between indoor residential radon exposure and risk of child-
hood AML. However, based on small numbers, there was an
apparent interaction between age- and radon-associated risk for
AML. Risk was decreased for children younger than 2, but
increased for children aged 2 and over. A similar pattern of risk
was seen in the Lubin et al (1998) study of radon and ALL,
although none of the trends were statistically significant. In that
study, odds ratios were below one for children younger than 2, for
whom odds ratios decreased with increasing radon concentration.
Odds ratios were greater than one for children aged 2–4 and age
10 and older and increased slightly with increasing radon concen-
tration among children 10 and older.
We estimated risks separately for children younger than 2 and
age 2 and older because childhood exposures may be less likely
than prenatal factors to play an aetiological role in the risk for
acute leukaemia diagnosed before age 2. However, the issue of
latency between exposure and diagnosis of AML is not straightfor-
ward. In contrast to adults, the developing fetus and the growing
child may be subject to different pathways for leukaemia induc-
tion. The only relevant data on latency is for postnatally exposed
children. There was a latency period of several years before
observing the peak occurrence of acute leukaemia following high
dose radiation exposure among paediatric survivors of Hiroshima
and Nagasaki (Ichimaru et al, 1981). Lower dose radiation expo-
sure, such as indoor radon, may require a longer exposure period.
The inverse association observed among children < 2 is unex-
plained and could be due to chance. On the other hand, AML in
infancy may have a distinct aetiology, with possible prenatal
origin. Onset during infancy would imply a shorter latency than
may be plausible for an environmental factor. While the observed
association between radon and AML in children aged 2 and older
also could be due to chance, it is also consistent with a possible
risk associated with increasing cumulative exposure to radon. The
association with radon was most evident among the subset of older
children who lived their entire life in the measured residence. For
this group, lifetime exposure to radon is least likely to be mis-
classified, and increasing TWA radon exposure will correlate with
age-dependent increasing cumulative exposure.
The mean radon levels observed in this study were substantially
lower than both the EPA and NRPB ‘action level’ for radon reme-
diation. These levels are well below those at which substantial
increases in risk would be expected, thus raising further questions
about the apparent subgroup effects.
When cases are widely distributed geographically, RDD repre-
sents a feasible approach for control selection. Not unlike many
control selection methods, use of RDD does raise the potential for
introduction of selection and subsequent bias since the method-
ology generally does not allow for detailed characterization of
subjects who refuse to provide identifying information or are not
reached after repeated attempts. Given this inability to fully char-
acterize non-participants, a systematic selection cannot be ruled
out. Moreover, it is unknown if, or how, systematic selection or
bias could impact the observed results. As demonstrated in the
current study, participating RDD controls are, as a group, of a
higher socioeconomic status, requiring adjustment for education
and income in the data analysis.
This study improves upon the previous ecological studies and is
the largest reported case–control study of residential radon expo-
sure and childhood AML. Other advantages of the study include
the direct collection of data from parents of cases and controls and
the availability of data on a large number of potential confounding
variables. Individual data on radon exposure were obtained via
placement of detectors on more than one level of a home for a
period of 1 year, and we were able to calculate a measure of radon
exposure that took into account the amount of time spent on each
level of the home (which may have different levels of radon). We
also took into account time spent away from home although we
could not directly account for any radon exposure outside of the
home. The quality assurance results for side-by-side placement of
radon detectors, as well as blank and spiked detectors, provide
some reassurance about the quality of the exposure data.
Despite the size of the study, the numbers for subgroup analysis
were limited and this precluded estimation of dose–response rela-
tionships that may vary with age at diagnosis. Another study limi-
tation relates to not collecting information on possible radon
remediation in the index residence which could have been differ-
ential between cases and controls. While it would have been desir-
able to characterize the lifetime radon exposure for all participants,
it was not feasible to do so. Therefore, some degree of misclassifi-
cation of exposure was introduced by the unmeasured years of
exposure. For those who lived in more than one home, the TWAIndoor radon exposure and risk of childhood AML 905
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exposure is less reflective of lifetime exposure than it is for those
who had only lived in the measured home. For those with multiple
residences, the relevant time-window of exposure may not have
been assessed. Furthermore, we did not collect information on
maternal residences during pregnancy. Therefore, even among the
lifetime subset, prenatal exposures may be misclassified, making
it difficult to evaluate the trends for leukaemia in the first 2 years
of life.
In summary, this study evaluated the role of indoor residential
radon exposure as a possible risk factor for childhood AML.
Overall, there was no association between residential radon expo-
sure and AML risk in children. The apparent positive association
between radon and risk of AML after age 2 must be interpreted
cautiously because of the limited sample size available for
subgroup analysis and the lack of consistency with other data on
effects of radiation levels as low as those observed in study homes.
Nevertheless, further investigation may be warranted.
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